These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 13936557)

  • 1. [Thromboelastographic studies on the blood clot structure in the Sanarelli-Shwartzman phenomenon].
    MULLER-BERGHAUS G; KRECKE HJ; LASCH HG
    Klin Wochenschr; 1963 Mar; 41():216-9. PubMed ID: 13936557
    [No Abstract]   [Full Text] [Related]  

  • 2. [The effect of streptokinase on the Sanarelli-Shwartzman phenomenon of the rabbit].
    Junge WD; Stark KH
    Z Geburtshilfe Gynakol; 1968; 169(3):320-9. PubMed ID: 4885434
    [No Abstract]   [Full Text] [Related]  

  • 3. [Consumption coagulopathy and lysis coagulopathy in the human equivalent of the Sanarelli-Shwartzman phenomenon (generalized Shwartzman phenomenon)].
    Graeff H; Kuhn W; Bleyl U
    Thromb Diath Haemorrh; 1967 Feb; 17(1-2):144-55. PubMed ID: 4230956
    [No Abstract]   [Full Text] [Related]  

  • 4. [CHANGES OF FREE THROMBOCYTE NUCLEOTIDES IN THE SANARELLI-SHWARTZMAN PHENOMENON].
    WEBER E; MALESSA S; LASCH HG
    Thromb Diath Haemorrh; 1963 Jul; 143():304-16. PubMed ID: 14081254
    [No Abstract]   [Full Text] [Related]  

  • 5. [Studies on the problem of blood coagulation disorder in the Sanarelli-Shwartzman phenomena (so-called generalized Shwartzman phenomenon) of the rabbit].
    KLEINMAIER H; GOERGEN K; LASCH HG; KRECKE HJ; BOHLE A
    Z Gesamte Exp Med; 1959; 132():275-94. PubMed ID: 14409739
    [No Abstract]   [Full Text] [Related]  

  • 6. [BLOOD LIPIDS AND INTRAVASCULAR COAGULATION IN THE PATHOGENESIS OF THE SANARELLI-SHWARTZMAN PHENOMENON].
    MUELLER-BERGHAUS G; HUTH K; KRECKE HJ; LASCH HG
    Schweiz Med Wochenschr; 1964 Oct; 94():1519-26. PubMed ID: 14318347
    [No Abstract]   [Full Text] [Related]  

  • 7. [Blood coagulation and serum lipids in pregnant rats following endotoxin injection--studies of the Sanarelli-Shwartzmann phenomenon].
    Obst R; Jannakopulos E; Urbaschek B; Huth K; Müller-Berghaus G
    Thromb Diath Haemorrh; 1971 Dec; 26(3):474-87. PubMed ID: 4947420
    [No Abstract]   [Full Text] [Related]  

  • 8. [Studies on fibrinolysis in equivalents of the Sanarelli-Shwartzman phenomenon in obstetrics. Immunochemical demonstration of derivatives of fibrin(ogen)].
    Steichele DF; Herschlein HJ
    Thromb Diath Haemorrh; 1967 Dec; 18(3-4):462-74. PubMed ID: 5590239
    [No Abstract]   [Full Text] [Related]  

  • 9. [Study of the influence of shock on the coagulation system in the Sanarelli-Shwartzman phenomenon].
    LASCH HG; RODRIGUEZ-ERDMANN F
    Hemostase; 1961 Jun; 1():161-6. PubMed ID: 14462578
    [No Abstract]   [Full Text] [Related]  

  • 10. [THE PHYSIOLOGICAL INHIBITORS OF BLOOD COAGULATION IN PATHOLOGICALLY INCREASED COAGULABILITY IN VIVO. I. CONSUMPTION COAGULOPATHY IN THE SHWARTZMAN-SANARELLI PHENOMENON].
    SCHIMPF K; CIBELLIUS A
    Klin Wochenschr; 1964 May; 42():431-5. PubMed ID: 14230116
    [No Abstract]   [Full Text] [Related]  

  • 11. [On the morphological and blood coagulation analytical changes after liquoid administration. Contribution to the pathogenesis of the Sanarelli-Shwartzman phenomenon].
    RODRIGUEZ-ERDMANN F; KRECKE HJ; LASCH HG; BOHLE A
    Z Gesamte Exp Med; 1960; 134():109-30. PubMed ID: 13742626
    [No Abstract]   [Full Text] [Related]  

  • 12. [ON THE EFFECT OF DRUGS ON INTRAVASCULAR CONSUMPTION COAGULOPATHY CAUSED BY SHOCK (WITH A REFERENCE TO THE SANARELLI-SHWARTZMAN PHENOMENON)].
    NIESERT W; SCHNEIDER J
    Z Geburtshilfe Gynakol; 1965 Feb; 163():105-26. PubMed ID: 14346043
    [No Abstract]   [Full Text] [Related]  

  • 13. [The Sanarelli-Shwartzman phenomenon in the animal experiment].
    Krecke HJ
    Dtsch Med J; 1967 Jun; 18(11):355-9. PubMed ID: 5607430
    [No Abstract]   [Full Text] [Related]  

  • 14. Blood clotting system in the pathogenesis of the Sanarelli-Shwartzman reaction of the rabbit.
    RodríguezErdmann F
    Experientia; 1964 Apr; 20(4):223. PubMed ID: 5854170
    [No Abstract]   [Full Text] [Related]  

  • 15. [ON THE EFFECT OF BLOOD COAGULATION INHIBITORS AND FIBRINOLYSIS ON THE SANARELLI-SHWARTZMAN PHENOMENON].
    HAUSTEIN KO; MARKWARDT F
    Thromb Diath Haemorrh; 1965 Mar; 13():60-4. PubMed ID: 14285979
    [No Abstract]   [Full Text] [Related]  

  • 16. [On the clinical picture and therapy of bacterial shock and the generalized Sanarelli-Shwartzman phenomenon].
    Herschlein HJ; Steichele DF
    Zentralbl Gynakol; 1968 May; 90(20):696-702. PubMed ID: 5668832
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical manifestation of the Sanarelli-Shwartzman phenomenon in dermatology. I. Herpes zoster generalisatus and the Sanarelli-Shwartzman phenomenon].
    RICHTER R; JOHNE HO
    Z Haut Geschlechtskr; 1950 May; 8(9):333-42. PubMed ID: 15431793
    [No Abstract]   [Full Text] [Related]  

  • 18. Coagulation changes induced by endotoxin and purified contact activation product.
    Barth P; Zimmermann R
    Thromb Diath Haemorrh; 1972 Oct; 28(2):280-8. PubMed ID: 4639660
    [No Abstract]   [Full Text] [Related]  

  • 19. [Microscopic changes of mesenteric capillaries in the Schwartzmann-Sanarelli-phenomenon and in endotoxic shock].
    Schönbach G; Rolffs J
    Langenbecks Arch Chir; 1968; 322():1198-203. PubMed ID: 5758709
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical manifestations of the Sanarelli-Shwartzman phenomenon in dermatology; acute febrile pemphigus and related diseases, and postoperative gangrene as manifestations of the Sanarelli-Shwartzman phenomenon].
    RICHTER R
    Arch Dermatol Syph; 1950; 190(4):317-40. PubMed ID: 15433262
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.